Skip to main content

Chinese scientists will be the first to use CRISPR gene editing in human patients

china crispr human cancer trial gene editing ala cas9
Image used with permission by copyright holder
Chinese scientists are preparing to set a world’s first by treating lung cancer patients with immune cells modified using the CRISPR–Cas9 gene editing technique. The team of clinical researchers hopes the modified immune cells will attack the cancer cells, offering a treatment option in cases where other conventional treatments have failed. “This technique is of great promise in bringing benefits to patients, especially the cancer patients whom we treat every day,” said lead oncologist Lu You from Sichuan University’s West China Hospital in an article published recently in Nature.

Lu and his team plan to extract T-cells from cancer patients and modify them using the CRISPR–Cas9 technique. The technology will knock out the PD-1 gene, which sits on the surface of the T-Cell and prevents the cell from attacking healthy cells that have the companion PD-L1 protein. Many cancer cells also express this standard PD-L1 marker as a defensive mechanism to prevent the body’s T-cells from attacking them. By disabling this PD-1 gene and removing the PD-1 protein, the modified T-cell will be free to destroy the cancer cells.

These modified, cancer-killing T-cells will be multiplied in the lab and then injected into a patient’s bloodstream where they will then make their way through the body to the cancer cells. The first phase of this human trial is designed to test whether this approach is safe to use in humans. One primary concern is the overstimulation of the immune system due to these newly introduced modified T-cells, which could attack healthy cells in other body systems. The team plans to start with a small dose of the modified T-cells and then gradually increase the dosage in a single test patient. The treatment will be closely monitored by the researchers to ensure the treatment is working to remove the cancer cells and not harming the body’s healthy cells in the process.

Scientists in the United States are planning similar human clinical trials, but they are not expected to receive full approval for the technique until the end of 2016. A team of researchers from the University of Pennsylvania in Philadelphia already received approval from the US National Institutes of Health (NIH), but are still waiting for the green light from the US Food and Drug Administration (FDA) and a university review board before they begin their trials.

Editors' Recommendations

Kelly Hodgkins
Kelly's been writing online for ten years, working at Gizmodo, TUAW, and BGR among others. Living near the White Mountains of…
Drone delivers lifesaving kidney for transplant patient in world first
drone delivers life saving kidney for transplant patient delivery

University of Maryland Unmanned Aircraft Used to Complete Kidney Transplant

Drone technology is increasingly proving itself across a variety of industries, including the medical field where the machine’s ability to be quickly deployed and move at speed across urban areas for vital deliveries can be a literal lifesaver.

Read more
Scientists manage to 3D print an actual heart using human cells
tel aviv university 3d printed heart screen shot 2019 04 16 at 40 19

Scientists at Tel Aviv University (TAU) announced the world’s first 3D-printed small-scale heart, complete with blood vessels, ventricles, and chambers -- a massive step forward for the field of 3D-printed organs, which aims to reshape the medical world.

Heart disease is the leading cause of death among both men and women in the United States. Although heart transplants represent a possible solution to this condition, there is an enormous shortage of donor hearts available. As a result, scientists are busy looking for innovative other ways of making hearts available for transplantation.

Read more
Chinese government may have helped fund controversial CRISPR babies experiment
CRISPR gene-editing technology

The controversial “CRISPR babies” experiment in China might have been carried out with the support of the Chinese government. According to a report by STAT, three governmental institutions -- including China’s science ministry -- may have contributed funding to the gene-altering experiments, which were harshly criticized by the international scientific community.

STAT claims to have seen a slide presentation prepared by researcher He Jiankui and his team. It listed funding sources for the experiment including China’s Ministry of Science and Technology, Shenzhen Science and Technology Innovation Commission, and Southern University of Science and Technology, where He was employed. While it is possible that these institutions were not aware of how their grant money was being used, if they did have knowledge of this it would mean that China funded research widely condemned as unethical.

Read more